|
1
|
Park YH, An M, Kim JK and Lim YH:
Antiobesity effect of ethanolic extract of Ramulus mori in
differentiated 3T3-L1 adipocytes and high-fat diet-induced obese
mice. J Ethnopharmacol. 251(112542)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Haslam DW and James WPT: Obesity. Lancet.
366:1197–1209. 2005.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Visscher TL and Seidell JC: The public
health impact of obesity. Ann Rev Public Health. 22:55–375.
2001.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Hofbauer KG, Nicholson JR and Boss O: The
obesity epidemic: Current and future pharmacological treatments.
Ann Rev Pharmacol Toxicol. 47:565–592. 2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Cheung BMY, Cheung TT and Samaranayake NR:
Safety of antiobesity drugs. Ther Adv Drug Saf. 4:171–181.
2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Javed T, Ashfaq UA, Riza S, Rehman S and
Riazuddin S: In-vitro antiviral activity of Solanum nigrum
against Hepatitis C Virus. Virol J. 8(26)2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Zakaria ZA, Gopalan HK, Zainal H, Pojan
NHM, Morsid NA, Aris A and Sulaiman MR: Antinociceptive,
anti-inflammatory and antipyretic effects of Solanum nigrum
chloroform extract in animal models. Yakugaku Zasshi.
126:1171–1178. 2006.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Lin HM, Tseng HC, Wang CJ, Chyau CC, Liao
KK, Peng PL and Chou FP: Induction of autophagy and apoptosis by
the extract of Solanum nigrum Linn in HepG2 cells. J Agric
Food Chem. 55:3620–3628. 2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Hsieh CC, Fang HL and Lina WC: Inhibitory
effect of Solanum nigrum on thioacetamide-induced liver
fibrosis in mice. J Ethnopharmacol. 119:117–121. 2008.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Peng CH, Cheng JJ, Yu MH, Chung DJ, Huang
CN and Wang CJ: Solanum nigrum polyphenols reduce body
weight and body fat by affecting adipocyte and lipid metabolism.
Food Funct. 11:483–492. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Lee ES, Choi SJ, Kim HD, Kang MH, Ji YJ,
Kim GS and Jang GY: Anti-obesity activity in 3T3-L1 cells of
Cornus officinalis fruits harvested at different times.
Processes. 10(2008)2020.
|
|
12
|
Getiye Y, Rice TA, Phillips BD, Carrillo
DF and He G: Dysregulated lipolysis and lipophagy in lipid droplets
of macrophages from high fat diet-fed obese mice. J Cell Mol Med.
26:4825–4836. 2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Krahmer N Jr, Farese RV and Walther TC:
Balancing the fat: Lipid droplets and human disease. EMBO Mol Med.
5:905–915. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Yang L, Jia X, Fang D, Cheng Y, Zhai Z,
Deng W, Du B, Lu T, Wang L, Yang C and Gao Y: Metformin inhibits
lipid droplets fusion and growth via reduction in cidec and its
regulatory factors in rat adipose-derived stem cells. Int J Mol
Sci. 23(5986)2022.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Lefterova MI and Lazar MA: New
developments in adipogenesis. Trends Endocrinol Metab. 20:107–114.
2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Rosen ED and MacDougald OA: Adipocyte
differentiation from the inside out. Nat Rev Mol Cell Biol.
7:885–896. 2006.PubMed/NCBI View
Article : Google Scholar
|
|
17
|
Tang QQ and Lane MD: Adipogenesis: From
stem cell to adipocyte. Ann Rev Biochem. 81:715–736.
2012.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Guo L, Kang JS, Kang NJ, Je BI, Lee YJ,
Park YH and Choi YW: Pelargonidin suppresses adipogenesis in 3T3-L1
cells through inhibition of PPAR-γ signaling pathway. Arch Biochem
Biophys. 686(108365)2020.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Millward CA, Heaney JD, Sinasac DS, Chu
EC, Bederman IR, Gilge DA, Previs SF and Croniger CM: Mice with a
deletion in the gene for CCAAT/enhancer-binding protein beta are
protected against diet-induced obesity. Diabetes. 56:161–167.
2007.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Spiegelman BM and Green H: Control of
specific protein biosynthesis during the adipose conversion of 3T3
cells. J Biol Chem. 255:8811–8818. 1980.PubMed/NCBI
|
|
21
|
Nakamura R, Okura T, Fujioka Y, Sumi K,
Matsuzawa K, Izawa S, Ueta E, Kato M, Taniguchi SI and Yamamoto K:
Serum fatty acid-binding protein 4 (FABP4) concentration is
associated with insulin resistance in peripheral tissues, A
clinical study. PLoS One. 12(e0179737)2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Fu Y, Luo N, Klein RL and Garvey WT:
Adiponectin promotes adipocyte differentiation, insulin
sensitivity, and lipid accumulation. J Lipid Res. 46:1369–1379.
2005.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Duncan RE, Ahmadian M, Jaworski K,
Sarkadi-Nagy E and Sul HS: Regulation of lipolysis in adipocytes.
Ann Rev Nutr. 27:79–101. 2007.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Lass A, Zimmermann RZ, Oberer M and
Zechner R: Lipolysis-A highly regulated multi-enzyme complex
mediates the catabolism of cellular fat stores. Prog Lipid Res.
50:14–27. 2011.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Langin D: Adipose tissue lipolysis as a
metabolic pathway to define pharmacological strategies against
obesity and the metabolic syndrome. Pharmacol Res. 53:482–491.
2006.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Lo KA and Sun L: Turning WAT into BAT: A
review on regulators controlling the browning of white adipocytes.
Biosci Rep. 33(e00065)2013.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kuryłowicz A and Puzianowska-Kuźnicka M:
Induction of adipose tissue browning as a strategy to combat
obesity. Int J Mol Sci. 21(6241)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
van der Vaart JI, Boon MR and Houtkooper
RH: The role of AMPK signaling in brown adipose tissue activation.
Cells. 10(1122)2021.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Cannon B and Nedergaard J: Brown adipose
tissue: Function and physiological significance. Physiol Rev.
84:277–359. 2004.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Seale P, Kajimura S, Yang W, Chin S, Rohas
LM, Uldry M, Tavernier G, Langin D and Spiegelman BM:
Transcriptional control of brown fat determination by PRDM16. Cell
Metab. 6:38–54. 2007.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhang X, Wu D, Wang C, Luo Y, Ding X, Yang
X, Silva F, Arenas S, Weaver JM, Mandell M, et al: Sustained
activation of autophagy suppresses adipocyte maturation via a
lipolysis-dependent mechanism. Autophagy. 16:1668–1682.
2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Singh R, Xiang Y, Wang Y, Baikati K,
Cuervo AM, Luu YK, Tang Y, Pessin JE, Schwartz GJ and Czaja MJ:
Autophagy regulates adipose mass and differentiation in mice. J
Clin Invest. 119:3329–3339. 2009.PubMed/NCBI View
Article : Google Scholar
|
|
33
|
Runwal G, Stamatakou E, Siddiqi FH, Puri
C, Zhu Y and Rubinsztein DC: LC3-positive structures are prominent
in autophagy-deficient cells. Sic Rep. 9(10147)2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Sathyanarayan A, Mashek MT and Mashek DG:
ATGL promotes autophagy/lipophagy via SIRT1 to control hepatic
lipid droplet catabolism. Cell Rep. 49:1–9. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Sztalryd C and Brasaemile DL: The
perilipin family of lipid droplet proteins: Gatekeepers of
intracellular lipolysis. Biochim Biophys Acta. 1862:1221–1232.
2017.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Jiang Y, Ding S, Li F, Zhang C,
Sun-Waterhouse D, Chen Y and Li D: Effects of (+)-catechin on the
differentiation and lipid metabolism of 3T3-L1 adipocytes. J Funct
Foods. 62(103558)2019.
|
|
37
|
Choi I, Park Y, Choi H and Lee EH:
Anti-adipogenic activity of rutin in 3T3-L1 cells and mice fed with
high-fat diet. Biofactors. 26:273–281. 2006.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Xu H, Wang L, Yan K, Zhu H, Pan H, Yang H,
Liu M and Gong F: Nuciferine iinhibited the differentiation and
lipid accumulation of 3T3-L1 preadipocytes by regulating the
expression of lipogenic genes and adipokines. Front Pharmacol.
12(632236)2021.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Hong SY, Ha AW and Kim W: Effects of
quercetin on cell differentiation and adipogenesis in 3T3-L1
adipocytes. Nutr Res Pract. 15:444–455. 2021.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kim H, Hiraishi A, Tsuchiya K and Sakamoto
K: (-) Epigallocatechin gallate suppresses the differentiation of
3T3-L1 preadipocytes through transcription factors FoxO1 and
SREBP1c. Cytotechnology. 62:245–255. 2010.PubMed/NCBI View Article : Google Scholar
|
